Open Beta
TREN
MetriLume
TREN

US marketsSILO

SEC-sourced researchBeta

SILO

Silo Pharma, Inc.

Company comparison ↗

Data passport

CIK
0001514183
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 72,102.0000 USD; December 2025: 72,102.0000 USD72.1K USD0 USD0December 2024December 2025
SILO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202472,102.0000Mar 27, 2026
December 202572,102.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202572,102.0000-4,227,698.0000-4,661,339.00007,605,100.00001,299,659.0000Mar 27, 2026
December 202472,102.0000-4,392,880.0000-3,833,914.00007,411,840.00002,377,575.0000Mar 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$72.1KDecember 2025Mar 27, 202610-K
Previous period revenueRevenues$72.1KDecember 2024Mar 27, 202610-K
Net incomeNetIncomeLoss-$4.23MDecember 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$4.66MDecember 2025Mar 27, 202610-K
Total assetsAssets$7.61MDecember 2025Mar 27, 202610-K
Total liabilitiesLiabilities$1.3MDecember 2025Mar 27, 202610-K

New filings

Explore methodology ↗